
Qingqing Cai, MD, PhD, discussed early efficacy data for rocbrutinib plus R-CHOP in untreated non-GCB DLBCL and how they compare with frontMIND at ESMO 2026.
This video reviews updates on the treatment and biology of splenic and nodal marginal zone lymphoma.
In this video, Catherine Thieblemont, MD, PhD, of Hopital Saint-Louis in Paris, discusses updates on the treatment and biology of splenic and nodal marginal zone lymphoma.
Thieblemont gave a presentation on this topic during an education session at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.

